
Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.
David Lin, Ph. D., is with the Biologics Consulting Group.

Almost half of pharmaceutical industry profits continue to come from biopharmaceuticals.

A two-day workshop on the "science behind pharmaceutical stability" was held in conjunction with the Annual Meeting of American Association of Pharmaceutical Scientists (AAPS) on Oct. 21-22, 2011 in Washington, DC.

Published: October 2nd 2021 | Updated:

Published: November 3rd 2012 | Updated: